ConvaTec Group PLC (LON:CTEC) Receives GBX 307.17 Consensus PT from Brokerages

Shares of ConvaTec Group PLC (LON:CTEC) have been given a consensus rating of “Buy” by the six analysts that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have issued ratings on the stock in the last year is GBX 307.17 ($3.90).

CTEC has been the topic of a number of recent research reports. JPMorgan Chase & Co. raised their price objective on shares of ConvaTec Group from GBX 300 ($3.81) to GBX 323 ($4.11) and gave the company an “overweight” rating in a research note on Thursday, March 7th. Berenberg Bank upped their target price on shares of ConvaTec Group from GBX 290 ($3.69) to GBX 310 ($3.94) and gave the stock a “buy” rating in a report on Wednesday, March 6th.

ConvaTec Group Price Performance

Shares of LON:CTEC opened at GBX 251.60 ($3.20) on Tuesday. The stock’s 50 day moving average is GBX 274.26 and its 200-day moving average is GBX 251.94. ConvaTec Group has a twelve month low of GBX 195.10 ($2.48) and a twelve month high of GBX 295.20 ($3.75). The company has a quick ratio of 0.96, a current ratio of 1.62 and a debt-to-equity ratio of 77.53. The firm has a market capitalization of £5.16 billion, a price-to-earnings ratio of 5,032.00, a PEG ratio of 2.10 and a beta of 0.60.

ConvaTec Group Increases Dividend

The company also recently disclosed a dividend, which was paid on Thursday, May 23rd. Shareholders of record on Thursday, April 25th were paid a $0.04 dividend. This is a positive change from ConvaTec Group’s previous dividend of $0.02. The ex-dividend date was Thursday, April 25th. This represents a yield of 1.39%. ConvaTec Group’s dividend payout ratio (DPR) is 10,000.00%.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.